U.S. Real Estate Stock News

GH Research (NasdaqGM:GHRS) put fresh clinical data in front of investors with full Phase 2a results for inhaled GH001 in postpartum depression, along with new oral presentations accepted for the CINP 2026 congress. See our latest analysis for GH Research. The stock has eased over the past month despite the latest clinical update, with a 30 day share price return of about 1% lower. However, momentum over longer periods remains strong, including a 90 day share price return of 39.77% and a 1...

Douglas Emmett (DEI) has drawn investor attention after recent trading, with the stock last closing at US$12.28. You may be considering how this real estate investment trust’s fundamentals compare with its recent performance. See our latest analysis for Douglas Emmett. Recent trading has come after a period where the stock’s 90 day share price return of 27.78% contrasts with a 1 year total shareholder return that is down 12.45%. This suggests improving short term momentum after a weaker...

In recent weeks, Old Republic International has faced ongoing scrutiny as slower net premium growth, higher expenses, and weaker margins have weighed on earnings quality, even as the company continues buybacks and a higher regular dividend. At the same time, a jump in implied volatility on near-term call options suggests traders are bracing for a sharper move in the shares tied to these profitability pressures. Now, we'll examine how these concerns over rising expenses and margin pressure...

Recent analyst upgrades for Relay Therapeutics (RLAY) focus on early clinical data for its drug candidate zovegalisib. Initial results in PIK3CA-driven vascular anomalies, particularly in heavily treated patients, have drawn increased attention to the stock. See our latest analysis for Relay Therapeutics. The recent enthusiasm around zovegalisib comes on top of strong price momentum, with a 1-month share price return of 21.39%, a 3-month share price return of 46.20% and a year-to-date share...

Earlier this month, Diehl Defence announced it had signed a Memorandum of Understanding with Spire Global at the ILA Berlin Airshow 2026 to explore collaboration on satellite-based intelligence and early warning against ballistic and hypersonic missiles, drawing on Spire’s RF detection and analytics capabilities. This collaboration framework, paired with Spire’s new Munich facility capable of producing up to 100 satellites per year, highlights how the company is positioning itself as a...

Tronox Holdings has released its 2025 sustainability report, confirming it exceeded its environmental and safety targets and permanently closed its Fuzhou TiO₂ plant in China to better align operations with market conditions. The report links these environmental gains and footprint changes with progress in Tronox’s rare earths program, underscoring how sustainability efforts are being tied directly to future product and market opportunities. Next, we’ll examine how Tronox’s progress in rare...

Earlier this month, Goldman Sachs upgraded New Oriental Education & Technology Group from Neutral to Buy, highlighting the company’s approximately US$5.40 billion net cash position and expectations for margin expansion in test preparation and livestreaming businesses. This reassessment by a major global bank underscores how New Oriental’s substantial cash reserves and improving profitability profile may be reshaping perceptions of its financial resilience. Next, we’ll examine how Goldman...

Digital Realty Trust’s recent annual meeting results showed shareholders rejecting a proposal for enhanced water-risk disclosure, while the company moved ahead with AI-focused initiatives including a new Barcelona data center and a private AI infrastructure partnership with ePlus. At the same time, Baron Capital’s decision to increase its holdings points to growing institutional interest in Digital Realty’s role as an AI and cloud infrastructure landlord. We’ll now explore how the private AI...

York Space Systems (YSS) saw its stock drop more than 16% on June 12, 2026, after investors reacted to the planned SpaceX IPO and ongoing concerns around York’s profitability and sector volatility. See our latest analysis for York Space Systems. That sharp 1 day share price return of down 17.9% sits against a 30 day share price return of 15.3% and a 90 day share price return of 39.7%. This suggests recent momentum had been building before the latest pullback as investors weighed York’s...

Recent analyst activity around Karooooo (KARO) has focused on a series of upward earnings estimate revisions and an improved ranking. This has prompted investors to reassess how the stock’s recent performance aligns with these expectations. See our latest analysis for Karooooo. Karooooo’s recent 3.8% 1 day share price return at US$47.27 and 5.8% year to date share price return sit against a very large 3 year total shareholder return of about 12x, suggesting investors are weighing earlier...

H2O America recently announced that executive Kristen Johnson will depart the company without cause, effective 3 July 2026, with severance provided under her employment agreement. Alongside this leadership change, H2O America has extended its 58-year dividend growth streak with a 4.8% quarterly increase and reaffirmed its 2026 earnings guidance. Next, we’ll examine how Johnson’s departure and the continued dividend growth track record may influence H2O America’s broader investment...

Bolt, Pony.ai, and Stellantis recently launched an autonomous mobility pilot in Luxembourg to test Pony.ai’s seventh-generation robotaxi on Stellantis’ L4-Ready midsize vans using Bolt’s ride-hailing platform. The project highlights Luxembourg’s supportive regulatory framework as a proving ground for validating Pony.ai’s autonomous driving technology and readiness for future European deployment. Next, we will examine how this European pilot, especially testing seventh-generation autonomous...

We wouldn't blame Expedia Group, Inc. ( NASDAQ:EXPE ) shareholders if they were a little worried about the fact that...

Ooma, Inc.'s ( NYSE:OOMA ) earnings announcement last week was disappointing for investors, despite the decent profit...

Investors may be considering whether W.W. Grainger at around US$1,315 per share still offers value, or if most of the opportunity is already priced in. The stock has posted returns of 1.2% over the last week, 3.4% over the last month, 31.1% year to date and 24.7% over the past year, which can change how investors think about both its potential and its risks. Recent coverage has focused on W.W. Grainger's role in industrial distribution and how it is positioning its operations and customer...

We wouldn't blame NRC Health ( NASDAQ:NRC ) shareholders if they were a little worried about the fact that Michael...

With war in Iran disrupting oil supplies, energy prices jumping and inflation back at a three year high, the mood in markets has shifted fast. Higher U.S. Treasury yields and talk of fresh Federal Reserve rate hikes are putting pressure on richly priced growth stories, while investors pay closer attention to cash flow and balance sheet strength. Dividend growth stocks with solid financial footing can look appealing in this kind of backdrop, but not all are affected in the same way. This...

Kennedy-Wilson Holdings (KW) has attracted fresh attention after recent trading, with the stock last closing at $10.93. For investors, that price stands in the context of mixed recent returns and sizeable exposure to global real estate. See our latest analysis for Kennedy-Wilson Holdings. Recent trading has been relatively muted, with a 1 day share price return of 0.09% and a 30 day share price return of 0.91%. However, a 13.38% year to date share price return sits alongside a 1 year total...

Some The J. M. Smucker Company ( NYSE:SJM ) shareholders may be a little concerned to see that the Chief Legal Officer...

Some Gen Digital Inc. ( NASDAQ:GEN ) shareholders may be a little concerned to see that the Director, Ondrej Vlcek...

The recent 17% drop in CervoMed Inc.'s ( NASDAQ:CRVO ) stock could come as a blow to insiders who purchased US$455.1k...

We wouldn't blame Centene Corporation ( NYSE:CNC ) shareholders if they were a little worried about the fact that...

SpaceX’s record US$75b IPO and US$2t market cap have grabbed headlines, but the ripple effects may matter more for you as an investor. Fresh enthusiasm for mega-IPOs and high-growth stories is colliding with questions about rich valuations and business risk. That mix of optimism and caution is now spilling over into other recently listed large caps that could one day qualify for major indices. This article highlights 3 stocks from our Index Inclusion Beneficiaries screener that are especially...

Structure Therapeutics (GPCR) drew attention after publishing Phase 2b ACCESS trial data for its oral GLP-1 candidate aleniglipron in Nature Medicine, alongside a detailed presentation at the American Diabetes Association’s 86th Scientific Sessions. See our latest analysis for Structure Therapeutics. The latest data release has arrived against a mixed price backdrop, with the stock at US$42.93 after a strong 7 day share price return of 14.24%. This contrasts with a weaker 90 day share price...